PEDRO
GONZALEZ MENENDEZ

With over 10 years in biomedical research, I have published 18 original articles and 6 reviews, serving as first author on five and co-corresponding author on three. Eight are in D1 journals and 14 in Q1. My work has more than 800 citations and a h-index of 14. I began in immunology at the University of Oviedo, publishing my first first-author paper. During my PhD in Dr. Sainz’s lab, supported by the FPU program, I researched GLUT transporters in prostate cancer. I published three first-author papers and contributed to eight others, collaborating on two Spanish Government projects and a contract with Bioquochem S.L. My thesis work earned oral presentations, international travel grants, and the Extraordinary Thesis Award. I also supervised two final degree projects, taught, and organized outreach events. I was awarded a European Association for Cancer Research short stay in Naomi Taylor’s lab at CNRS, later joining as a postdoctoral researcher. Supported by the Clarin-COFUND EU Program and an NIH PO1 grant, I studied mitochondrial oxidative stress and hypusinated-eIF5A’s role in translation during erythropoiesis. I published two papers as first and co-corresponding author, trained MSc and PhD students, and presented my work at major conferences (Gordon Research Conference in Red Cells, European School of Hematology conference, etc.). I also reviewed for journals, and evaluated for research funding calls in France and Poland. In August 2022, I returned to the University of Oviedo on a “María Zambrano” grant, becoming a “Ramón y Cajal” researcher in January 2023. I co-supervised a PhD student, contribute to scientific dissemination, and recently participated at the Gordon Research Conference in Red Cells as guest. In 2023, I started a SFRR-Europe/OCC ECR Fellowship and was awarded a Spanish Government “Generación del Conocimiento 2022” grant to study the role of protein synthesis in hematopoiesis (2023-2026).